We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Blackrock
BLK
$176B
| $159M | 0.28% |
237,508
-1,770
| -0.7% | -$1.25M |
|
52
Mercado Libre
MELI
$92.3B
| $141M | 0.25% |
107,286
-156
| -0.1% | -$177K |
|
53
TSMC
TSM
$2.18T
| $138M | 0.24% |
1,487,639
+46,107
| +3% | +$4.14M |
|
54
Texas Instruments
TXN
$261B
| $137M | 0.24% |
734,762
+73,433
| +11% | +$12.9M |
|
55
Alnylam Pharmaceuticals
ALNY
$29.3B
| $132M | 0.23% |
658,226
-54,330
| -8% | -$11.4M |
|
56
Nike
NKE
$61.9B
| $130M | 0.23% |
1,059,773
+318,674
| +43% | +$39.2M |
|
57
Adobe
ADBE
$105B
| $126M | 0.22% |
328,238
-2,662
| -0.8% | -$946K |
|
58
Diamondback Energy
FANG
$52.7B
| $115M | 0.2% |
+853,491
| New | +$119M |
|
59
KBR
KBR
$4.8B
| $111M | 0.19% |
2,020,027
+7,453
| +0.4% | +$390K |
|
60
Rambus
RMBS
$11B
| $102M | 0.18% |
1,995,172
-474,945
| -19% | -$20.4M |
|
61
Texas Roadhouse
TXRH
$13.7B
| $98.6M | 0.17% |
912,252
+77,104
| +9% | +$7.89M |
|
62
WillScot Mobile Mini Holdings
WSC
$4.41B
| $97.3M | 0.17% |
2,074,779
-440,346
| -18% | -$21.2M |
|
63
Option Care Health
OPCH
$3.56B
| $95.6M | 0.17% |
3,007,780
+72,790
| +2% | +$2.18M |
|
64
Silicon Laboratories
SLAB
$7.23B
| $94.5M | 0.16% |
539,609
+230
| +0% | +$38.7K |
|
65
RBC Bearings
RBC
$18B
| $92M | 0.16% |
395,109
+1,529
| +0.4% | +$352K |
|
|
P
66
Everpure Inc
P
$29.9B
| $91M | 0.16% |
3,565,366
-11,305
| -0.3% | -$305K |
|
67
Hexcel
HXL
$7.82B
| $90M | 0.16% |
1,318,566
+117,209
| +10% | +$7.95M |
|
68
FTI Consulting
FCN
$4.18B
| $88.9M | 0.15% |
450,644
+1,045
| +0.2% | +$182K |
|
69
Doximity
DOCS
$4.88B
| $84.2M | 0.15% |
2,599,368
+57,703
| +2% | +$1.91M |
|
70
CONMED
CNMD
$1.47B
| $83.4M | 0.14% |
803,063
+47,747
| +6% | +$4.62M |
|
|
AXNX
71
DELISTED
Axonics, Inc. Common Stock
AXNX
| $81.8M | 0.14% |
1,498,694
+6,148
| +0.4% | +$359K |
|
72
Halozyme
HALO
$12.2B
| $81.3M | 0.14% |
2,129,204
+8,633
| +0.4% | +$405K |
|
73
Weatherford International
WFRD
$6.22B
| $81.3M | 0.14% |
1,369,005
-123,732
| -8% | -$7.25M |
|
|
74
Bank of America Series L
BAC.PRL
$3.99B
| $81.1M | 0.14% |
+2,835,020
| New | +$3.4B |
|
75
Kinsale Capital Group
KNSL
$8.51B
| $79.2M | 0.14% |
263,725
+1,595
| +0.6% | +$467K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.